Application

16222379 · Treatment of NAFLD and NASH

Filed 2018-12-17 · Granted · Patent 10342770 (2019-07-09) The official file ↗The patent and its PDF ↗ · Art unit 1657 · Examiner Heidi L Reese Easy · CPC A61K 31/192 · CymaBay Therapeutics, Inc. · Gilead Sciences, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

1.8 mo

to disposition 6.7 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.